Immunization and Vaccines Development

Print

Technical support is provided to countries in the African Region in order to contribute to the reduction of morbidity, disability and mortality due to vaccine preventable diseases through achieving and sustaining high immunisation coverage, eradicating poliomyelitis, eliminating neonatal tetanus, controlling yellow fever and introducing new vaccines.

Meningitis A vaccine now recommended in routine immunization schedulesBrazzaville, 20 January 2015 – The World Health Organization (WHO) now recommends the conjugate meningitis A vaccine MenAfriVac® to be introduced in routine immunization schedules in sub-Saharan Africa. This recommendation ensures that infants are protected against meningitis and population-wide immunity is maintained.

The use of the MenAfriVac® vaccine to prevent meningitis A epidemics is one of the greatest vaccination success stories in public health history and highlights what partners can accomplish when unified by a compelling cause. In 2014, the MenAfriVac® campaigns reached more than 63 million people with remarkable success.
 
Striving to eradicate polio in the African Region
Striving to eradicate polio in the African Region
The WHO African Region is reporting rapid progress towards interrupting wild poliovirus (WPV) transmission. Following the steady decline since 2006, only 17 cases of polio have been reported in 2014 compared to 74 cases in the same period in 2013.
For the first time in history, no cases of WPV have been reported in the African Region in over 4 months. In 2014, six cases of polio were reported in Nigeria, five in Cameroon, five in Equatorial Guinea, and one in Ethiopia.

 
Topics

Integrated child survival interventions

Measles Elimination

Monitoring and Evaluation

Polio Eradication

Reach Every District (RED) Approach

Tetanus Elimination

Vaccine Research and Development

Yellow Fever Control